Cargando…
Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis
OBJECTIVES: Tuberculous meningitis is characterized by elevated levels of matrix metalloproteinase 9 (MMP9) in the cerebrospinal fluid (CSF). However, it is unclear whether elevated MMP9 levels are associated with poor treatment outcome. We tested the hypothesis that pretreatment MMP9 levels in the...
Autores principales: | Mailankody, Sharada, Dangeti, Gurukiran V., Soundravally, Rajendiran, Joseph, Noyal M., Mandal, Jharna, Dutta, Tarun K., Kadhiravan, Tamilarasu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507543/ https://www.ncbi.nlm.nih.gov/pubmed/28704492 http://dx.doi.org/10.1371/journal.pone.0181262 |
Ejemplares similares
-
Cerebrospinal fluid cytokines, matrix metalloproteinases, HIV, and tuberculous meningitis
por: Tin, Sim Sai, et al.
Publicado: (2015) -
Molecular diagnosis, genetic diversity and drug sensitivity patterns of Mycobacterium tuberculosis strains isolated from tuberculous meningitis patients at a tertiary care hospital in South India
por: Krishnakumariamma, Krishnapriya, et al.
Publicado: (2020) -
Dexamethasone, Cerebrospinal Fluid Matrix Metalloproteinase Concentrations and Clinical Outcomes in Tuberculous Meningitis
por: Green, Justin A., et al.
Publicado: (2009) -
Cerebrospinal fluid cytokines and matrix metalloproteinases in human immunodeficiency seropositive and seronegative patients of tuberculous meningitis
por: Rai, Dheeraj, et al.
Publicado: (2014) -
Endogenous gene selection for relative quantification PCR and IL6 transcript levels in the PBMC’s of severe and non-severe dengue cases
por: Kumar, Vigneshwari Easwar, et al.
Publicado: (2018)